NAT10 and cervical cancer: In cervical cancer, NAT10-mediated ac4C modification of FOXP1 mRNA enhances the invasion of regulatory T (Treg) cells in the immune microenvironment (TIME) of cervical cancer by promoting glycolysis and inducing the occurrence of cervical cancer immunosuppression, thus accelerating the development of cervical cancer [94].